RF9 is an NPFF1 and NPFF2 inhibitor
CAT No: R1882
CAS No:876310-60-0
Synonyms/Alias:876310-60-0;RF9;2-ADAMANTANECARBONYL-ARG-PHE-NH2 TRIFLUOROACETATE;1-Adamantanecarbonyl-RF-NH2;RF9 trifluoroacetate salt;CHEMBL1672380;1-adamantanecarbonyl-Arg-Phe-NH2;RF 9;RF 9 TFA;GTPL1486;SCHEMBL18041259;CHEBI:140980;DTXSID001151466;BDBM50336912;AKOS024457741;CS-7903;NCGC00485847-01;AS-77961;DA-67180;FR108335;PD045604;PD119376;HY-107382;D93586;Q27088538;N2-(Tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)-L-arginyl-L-phenylalaninamide;N(2)-(tricyclo[3.3.1.1(3,7)]decan-1-ylcarbonyl)-L-arginyl-L-phenylalaninamide;Adamantane-1-carboxylic acid [(S)-1-((S)-1-carbamoyl-2-phenyl-ethylcarbamoyl)-4-guanidino-butyl]-amide;
Chemical Name:N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]adamantane-1-carboxamide
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.